These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38791761)

  • 1. Investigating the Barriers and Facilitators to Using Antiretroviral Therapy among Women Living with HIV in Plateau State, Nigeria.
    Osayi EO; Blake SC; Afolaranmi T; Ajayi O; Onyeji J; Sagay AS; Anderson A; Obindo TJ
    Int J Environ Res Public Health; 2024 Apr; 21(5):. PubMed ID: 38791761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy initiation and adherence in rural South Africa: community health workers' perspectives on barriers and facilitators.
    Loeliger KB; Niccolai LM; Mtungwa LN; Moll A; Shenoi SV
    AIDS Care; 2016 Aug; 28(8):982-93. PubMed ID: 27043077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
    Gilbert HN; Wyatt MA; Pisarski EE; Muwonge TR; Heffron R; Katabira ET; Celum CL; Baeten JM; Haberer JE; Ware NC
    J Acquir Immune Defic Syndr; 2019 Nov; 82(3):265-274. PubMed ID: 31609925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.
    Mitchell KM; Lépine A; Terris-Prestholt F; Torpey K; Khamofu H; Folayan MO; Musa J; Anenih J; Sagay AS; Alhassan E; Idoko J; Vickerman P
    AIDS; 2015 Sep; 29(15):2035-44. PubMed ID: 26355574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1 serodiscordant couples in East Africa: a qualitative evaluation study in Uganda.
    Ware NC; Pisarski EE; Nakku-Joloba E; Wyatt MA; Muwonge TR; Turyameeba B; Asiimwe SB; Heffron RA; Baeten JM; Celum CL; Katabira ET
    J Int AIDS Soc; 2018 May; 21(5):e25113. PubMed ID: 29851436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving treatment implementation among HIV-infected pregnant women and their partners: results from a national surveillance study in Italy, 2001-2015.
    Floridia M; Frisina V; Ravizza M; Marconi AM; Pinnetti C; Cetin I; Sansone M; Molinari A; Cervi F; Meloni A; Luzi K; Masuelli G; Tamburrini E;
    J Glob Health; 2017 Jun; 7(1):010407. PubMed ID: 28567279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitators and Barriers of Antiretroviral Therapy Initiation among HIV Discordant Couples in Kenya: Qualitative Insights from a Pre-Exposure Prophylaxis Implementation Study.
    Patel RC; Odoyo J; Anand K; Stanford-Moore G; Wakhungu I; Bukusi EA; Baeten JM; Brown JM
    PLoS One; 2016; 11(12):e0168057. PubMed ID: 27930740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.
    Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O
    BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnant women with HIV in rural Nigeria have higher rates of antiretroviral treatment initiation, but similar loss to follow-up as non-pregnant women and men.
    Aliyu MH; Blevins M; Megazzini KM; Parrish DD; Audet CM; Chan N; Odoh C; Gebi UI; Muhammad MY; Shepherd BE; Wester CW; Vermund SH
    Int Health; 2015 Nov; 7(6):405-11. PubMed ID: 26012740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers.
    Bardon AR; Simoni JM; Layman LM; Stekler JD; Drain PK
    AIDS Res Ther; 2020 Aug; 17(1):50. PubMed ID: 32762713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'If I am given antiretrovirals I will think I am nearing the grave': Kenyan HIV serodiscordant couples' attitudes regarding early initiation of antiretroviral therapy.
    Curran K; Ngure K; Shell-Duncan B; Vusha S; Mugo NR; Heffron R; Celum C; Baeten JM
    AIDS; 2014 Jan; 28(2):227-33. PubMed ID: 24413310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation.
    Ngure K; Heffron R; Curran K; Vusha S; Ngutu M; Mugo N; Celum C; Baeten JM
    AIDS Patient Care STDS; 2016 Feb; 30(2):78-83. PubMed ID: 26836236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness.
    Heffron R; Ngure K; Velloza J; Kiptinness C; Quame-Amalgo J; Oluch L; Thuo N; Njoroge J; Momanyi R; Gakuo S; Mbugua S; Morrison S; Haugen H; Chohan B; Celum C; Baeten JM; Mugo N
    J Int AIDS Soc; 2019 Apr; 22(4):e25261. PubMed ID: 30957420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
    Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
    PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the acceptability of Option B plus among HIV-positive Nigerian women engaged and not engaged in the prevention of mother-to-child transmission of HIV cascade: a qualitative study.
    Erekaha SC; Cornelius LJ; Bessaha ML; Ibrahim A; Adeyemo GD; Fadare M; Charurat M; Ezeanolue EE; Sam-Agudu NA
    SAHARA J; 2018 Dec; 15(1):128-137. PubMed ID: 30253709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing adherence to antiretroviral therapy from the experience of people living with HIV and their healthcare providers in Sierra Leone: a qualitative study.
    Lahai M; Theobald S; Wurie HR; Lakoh S; Erah PO; Samai M; Raven J
    BMC Health Serv Res; 2022 Nov; 22(1):1327. PubMed ID: 36348488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.